What to look for in Pfizer earnings

Pfizer is expected to discuss its plans for dealing with a shrinking product line as some of its key patents expire.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.